SeaStar Medical Holding Corp

SeaStar Medical Holding Corp resulted from the business combination between LMF Acquisition Opportunities, Inc., a blank-check company trading under the ticker LMAO, and SeaStar Medical, Inc., a medical-device developer focused on selective cytopheretic device technology for treating acute inflammatory conditions including acute kidney injury. The SPAC was sponsored by LMF Acquisition Opportunities Sponsor LLC and completed its initial public offering in 2021, targeting the healthcare and medical-device sector. The August 2022 Form 8-K filing, bearing accession number 0001193125-22-228644, reflects a material disclosure event in connection with the de-SPAC transaction process. The combined company operates in the medical-technology space and trades on Nasdaq. Sign up at SpacDesk for full filing history, timeline data, and sponsor analytics on SeaStar Medical and hundreds of other SPAC transactions.